Olivier Lambotte

Vice Dean

Université Paris-Saclay

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Olivier Lambotte is the Vice Dean at Université Paris-Saclay in France. His research focuses on the intersection of infectious diseases and oncology, with recent publications addressing topics such as HHV8-related Castleman disease, the gut microbiome in HIV patients, and the safety of immune checkpoint inhibitors in individuals with HIV. He is also involved in studies regarding the pharmacokinetics of antiretroviral therapy and the effects of immunotherapy in cancer treatment.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (5)

Aurélie Barrail-Tran

Université Paris-Saclay

FRANCE

View details

Layal Rached

Institut Gustave Roussy

FRANCE

View details

Jean‐Marie Michot

FRANCE

View details

Julien Dang

Assistant Professor

Hôpital Ambroise-Paré

FRANCE

View details

Maud Salmona

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olivier Lambotte

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome

Combined Flow‐Fluorescence in situ hybridization to HHV‐8 and EBV reveals the viral heterogeneity of primary effusion lymphoma

Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations

HHV8-related Castleman disease presenting with nephrotic syndrome and pauci-immune glomerulonephritis.

Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates

Long term follow-up of the STOPAGO study.

Major depletion of insulin sensitivity-associated taxa in the gut microbiome of persons living with HIV controlled by antiretroviral drugs.

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.

Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports.

Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.

Collaborators (5)

Aurélie Barrail-Tran

Layal Rached

Jean‐Marie Michot

Julien Dang

Maud Salmona

Make your next move.